2 recruiting. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow HGBL, Nos: new trials by email Literature Review of HGBL, Nos trials Research Report on HGBL, Nos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma C402-CD19-CAR - Diffuse Large B-cell-lymphoma, DLBCL, Nos Genetic Subtypes | Phase 1 | Recruiting | Shanghai Exuma Biotechnology Ltd. | 18 | 2025-03-25 | 2026-09-11 |
| Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma 131-I Apamistamab, CAR T-cell - B-ALL, DLBCL | Early Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 12 | 2021-02-02 | 2026-02-17 |
Pyloric Stenosis, Hypertrophic (2) · Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Digestive System Diseases (2) · Gastric Outlet Obstruction (2) · Gastrointestinal Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pyloric Stenosis (2) · Stomach Diseases (2) · Histiocytic Disorders, Malignant (1)
Memorial Sloan Kettering Cancer Center (1) · Shanghai Exuma Biotechnology Ltd. (1)
China (1) · United States (1)
Liang Huang, MD (1) · Mark B Geyer, MD (1)